FTO in Lung Cancer : Its Progression and Therapeutic Potential
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
One of the most fatal and frequent malignancies on the planet is lung cancer. Its occurrence and development are the results of multifactorial and multigenic interactions. In recent years, RNA N6-methyladenosine transferase (FTO) has gained significant attention in the field of oncology. FTO is the first RNA demethylase to be found to control target mRNA demethylation. The growth, proliferation, and metastasis of tumor cells are greatly influenced by FTO. Recent studies have found that imbalanced m6A methylation regulatory proteins can induce disruption of downstream RNA metabolism, strongly affecting tumor development. This paper provides an overview of the relationship between FTO and lung cancer, discussing the mechanisms by which FTO is involved in lung cancer and its potential clinical applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Combinatorial chemistry & high throughput screening - (2024) vom: 12. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Xue-Fen [VerfasserIn] |
---|
Links: |
---|
Themen: |
FTO |
---|
Anmerkungen: |
Date Revised 14.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0113862073281598240227072839 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369753674 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369753674 | ||
003 | DE-627 | ||
005 | 20240315234537.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240315s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0113862073281598240227072839 |2 doi | |
028 | 5 | 2 | |a pubmed24n1330.xml |
035 | |a (DE-627)NLM369753674 | ||
035 | |a (NLM)38485681 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Xue-Fen |e verfasserin |4 aut | |
245 | 1 | 0 | |a FTO in Lung Cancer |b Its Progression and Therapeutic Potential |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 14.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a One of the most fatal and frequent malignancies on the planet is lung cancer. Its occurrence and development are the results of multifactorial and multigenic interactions. In recent years, RNA N6-methyladenosine transferase (FTO) has gained significant attention in the field of oncology. FTO is the first RNA demethylase to be found to control target mRNA demethylation. The growth, proliferation, and metastasis of tumor cells are greatly influenced by FTO. Recent studies have found that imbalanced m6A methylation regulatory proteins can induce disruption of downstream RNA metabolism, strongly affecting tumor development. This paper provides an overview of the relationship between FTO and lung cancer, discussing the mechanisms by which FTO is involved in lung cancer and its potential clinical applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a FTO | |
650 | 4 | |a RNA m6A | |
650 | 4 | |a lung cancer | |
650 | 4 | |a research progres FTO | |
650 | 4 | |a research progress | |
700 | 1 | |a Gong, Chen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Combinatorial chemistry & high throughput screening |d 1998 |g (2024) vom: 12. März |w (DE-627)NLM097489352 |x 1875-5402 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:12 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0113862073281598240227072839 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 12 |c 03 |